An alliance of clinical institutions in New York City has attracted clinical studies and research dollars to the numerous medical schools and hospitals in the city, according to the group's president. Opportunities are up, and start-up time is down. But the group has also benefited other research facilities around the country and now has more than 100 affiliates in 18 states.

In the late 1990s, officials at the New York Academy of Medicine had noticed that the number of clinical trials taking place in New York City had dropped from a decade earlier. Although there were many reasons for the decline, one of the main ones was that bureaucratic issues at academic institutions had delayed projects from starting and had discouraged sponsors from future collaborations. In response, the academy, along with five New York City–area institutions, formed the Biomedical Research Alliance of New York (BRANY) in 1998.

Since then, BRANY...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?